HOME >> BIOLOGY >> NEWS
New placenta screening for high-risk pregnancies

Toronto, ON (April 2, 2007) -- For the first time ever, a team of Toronto researchers are using a combination of ultrasound and blood tests to screen high-risk pregnant mothers for placental damage. By completing these non-invasive tests, most high-risk mothers can be reassured that their placenta is formed and functioning properly, so they can expect a healthy pregnancy. The tests are done early enough, at 16 to 23 weeks gestation, so if results are abnormal, physicians have time to improve pregnancy outcomes. Close to 40 per cent of high-risk mothers we see in our clinic experience placental damage, says Dr. John Kingdom, Principal Investigator of the study and Maternal-Fetal Medicine Specialist at Mount Sinai Hospital. The research is among the first to look at placenta health a vital life line between mother and fetus through which nutrients, oxygen, antibodies and hormones pass.

By identifying early on if there is a potential risk of complications, we can do everything possible to ensure the safety of both the mother and fetus, says Dr. Kingdom, who is also a Professor in the Department of Obstetrics and Gynaecology at the University of Toronto. We can reassure those with normal test results that their placentas are functioning well and they can expect a healthy pregnancy and birth.

If the placenta is not functioning properly it could be a potential danger to the health of the mother and fetus. Abnormalities can lead to conditions such as preeclampsia, which is maternal high blood pressure, stillbirth or the need for a pre-term delivery.

The screening tests include: a maternal serum screening test used to detect Downs syndrome, which measures the hormone levels in the mothers blood; a uterine artery Doppler blood flow test, which checks the maternal blood flow in the placenta; and an ultrasound of the placental shape. Of the 212 high-risk women in the study, 19 delivered early due to poor fetal growth. None of these women h
'"/>

Contact: Jodi Salem
416-586-3161
University of Toronto
2-Apr-2007


Page: 1 2

Related biology news :

1. 100 percent of pregnant women have at least one kind of pesticide in their placenta
2. Robust time estimation reconciles views of the antiquity of placental mammals
3. Tumor-suppressor gene is critical for placenta development
4. Key to early diagnosis of autism may be in the placenta
5. New research links placenta praevia directly to assisted reproductive techniques
6. Discarded placentas deliver researchers promising cells similar to embryonic stem cells
7. ACMG recognizes progress made in newborn screening
8. Nearly 90 percent of babies receive recommended newborn screening tests
9. Pre-implantation genetic screening reduces both ongoing pregnancy and live birth rates in over 35s
10. Changes in chromosomal constitution of preimplantation embryos suggest caution in genetic screening
11. Noninvasive screening in early pregnancy reduces Downs births by 50 percent

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/13/2017)... 2017 UBM,s Advanced Design and Manufacturing event ... emerging and evolving technology through its 3D Printing and ... alongside the expo portion of the event and feature ... focused on trending topics within 3D printing and smart ... event will take place June 13-15, 2017 at the Jacob ...
(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
(Date:4/11/2017)... 11, 2017 No two people are ... the New York University Tandon School of Engineering ... found that partial similarities between prints are common ... mobile phones and other electronic devices can be ... vulnerability lies in the fact that fingerprint-based authentication ...
Breaking Biology News(10 mins):
(Date:4/20/2017)... ... April 20, 2017 , ... USDM Life Sciences , the leading ... healthcare industries, is pleased to announce Holger Braemer as Vice President of ... GmbH” based in Germany. , Braemer is an integral part of USDM’s expansion ...
(Date:4/20/2017)... ... , ... Parallel6™ , the leader in mClinical™ technologies for improving patient ... one of the 2017 Top 10 eClinical Trial Management Solution Providers by Pharma ... “We take pride in honoring Parallel6 as one of the top 10 companies that ...
(Date:4/19/2017)... ... April 18, 2017 , ... The Vibrating Orifice Aerosol Generator ... generating monodisperse droplets of known diameters for research applications such as for calibrating ... by drying monodisperse droplets. , The VOAG requires forcing liquid out of ...
(Date:4/19/2017)... , ... April 19, 2017 , ... ... Series A-1 financing round. This event adds to several other early achievements at ... Executive and Scientific Teams. , ThermaGenix will use proceeds from the ...
Breaking Biology Technology:
Cached News: